GlassScriptPhysician profile
Sina Samie
NPI 1992191514
$8,202.55
in general payments reported to CMS, 2019-2025
19 companies · $217 in 2025
The $217 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,377 · 2020: $4,153 · 2021: $1,437 · 2022: $194 · 2023: $575 · 2024: $249 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,708.21 | 2019-2020 | |
| Boston Scientific Corporation | $2,669.06 | 2019-2025 | General - Pain Management, Intracept |
| Biohaven Pharmaceuticals, INC. | $1,200.00 | 2021 | |
| Abbott Laboratories | $815.34 | 2020-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $178.54 | 2023 | Intracept |
| Allergan, INC. | $170.02 | 2019-2021 | |
| Stryker Corporation | $64.82 | 2021-2022 | |
| Vertos Medical, INC. | $60.87 | 2020 | |
| Novartis Pharmaceuticals Corporation | $59.70 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.69 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.83 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $34.00 | 2025 | |
| Nalu Medical, INC. | $29.58 | 2024 | Nalu Neurostimulation System |
| Curonix LLC | $26.33 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $25.43 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $24.10 | 2023 | Ztlido |
| Daiichi Sankyo INC. | $23.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.80 | 2020 | |
| Depuy Synthes Sales INC. | $14.51 | 2023 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sina Samie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.